Another autoimmune CAR-T death; Treasury zeroes in on China deals

Coverage, in order

1. 16d ago
   
   BioPharma Dive indie

   Another autoimmune CAR-T death; Treasury zeroes in on China deals

   A patient who received Bristol Myers’ zola-cel died 44 days later. Elsewhere, Gilead paid nearly $1.3 billion for a potential threat to J&J’s newly approved psoriasis pill.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.